These results, along with a earlier report exhibiting that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 help the notion of targeting ACKR3 as a unique technique to modulate the opioid method, which could open new therapeutic avenues for opioid-associated disorders. Conolidine promises to generally be a https://wernerg395evl9.wikicorrespondent.com/user